Saturday 17 October 2026 Export SNYRQ’s income statement to Excel — free account

Synergy CHC Corp.

Synergy CHC Corp.’s revenue for fiscal 2025 (year ended December 2025) was $30.4 million, down 12.8% from fiscal 2024. In the quarter to March 2026, revenue fell 32.8%, EPS fell 330.0%, free cash flow fell 148.5% and total debt rose 7.08%, each against the same quarter a year earlier.

0.00 0.01 −100.00%

Follow SNYRQ

Alert me

Market cap: $1.3M
P/E: 0.0×
Fwd P/E: 1.6×
Dividend yield: —
F-score: 2/9
Altman Z: −7.00
Beneish M: −7.98
Dividend safety: n/a

Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 27.72%

Capital & Financial Ratios $m

Market Cap 1.34

Revenue 27.70

Net Income (15.79)

Free Cash Flow (3.81)

Net Debt 24.63

Current Ratio 0.93

Debt/Equity (0.98)

P/E ratio 0.00

Fwd P/E 1.60

P/S ratio 0.00

P/B ratio 0.00

Past 5Y EPS Growth —

This Y EPS Growth (553.60%)

Next Y EPS Growth 178.95%

Next Y revenue growth 3.68%

Next 5Y EPS Growth 28.56%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	1	1	3	0
Receivables	7	12	3	1
Inventory	4	2	4	3
Other	—	—	—	—
	12	16	10	6

	2023	2024	2025	Q'26
Payables	12	5	6	4
ST’ Debt	—	4	0	—
Other	0	0	0	—
	14	17	8	7

Compound Annual Growth %

	10y	5y	3y
Sales	—	—	(7.52%)
Cash Flow	—	—	0.00%
Earnings	—	—	0.00%
Book Value	—	—	0.00%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	5	—	—	—	—
’25	8	8	8	6	30
’24	9	8	7	10	35
’23	—	—	11	—	43

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(2)	—	—	—	—
’25	(1)	0	(2)	1	(3)
’24	(1)	0	0	(3)	(5)
’23	—	(2)	(1)	3	0

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(2)	—	—	—	—
’25	(1)	0	(2)	1	(3)
’24	(1)	0	0	(3)	(5)
’23	—	(2)	(1)	3	0

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.23)	—	—	—	—
’25	0.10	0.17	0.01	(1.35)	(1.27)
’24	0.08	0.09	0.10	0.01	0.28
’23	—	—	0.17	—	0.86

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	—	—	—	—	4.17	1.30	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	—	—	—	—	10.00	4.98
People
People	Employees	—	—	—	—	—	—	—	25	21	28
	Revenue/emp, $m	—	—	—	—	—	—	0.00	1.71	1.66	1.09
Income, $m
Income, $m	Revenue	—	—	—	—	—	—	38	43	35	30
	Gross margin, %	—	—	—	—	—	—	34.62	74.99	67.87	66.83
	EBT	—	—	—	—	—	—	(33)	7	2	(12)
	EBT margin, %	—	—	—	—	—	—	(84.87)	15.37	6.39	(40.23)
	Net income	—	—	—	—	—	—	(33)	6	2	(12)
	Depreciation	—	—	—	—	—	—	2	0	0	2
Per share, $
Per share, $	Revenue	—	—	—	—	—	—	5.08	5.80	4.59	3.12
	Earnings	—	—	—	—	—	—	(4.32)	0.86	0.28	(1.27)
	Cash flow	—	—	—	—	—	—	(1.12)	0.06	(0.63)	(0.27)
	Capex	—	—	—	—	—	—	0.00	0.00	0.00	0.00
	Free cash flow	—	—	—	—	—	—	(1.12)	0.06	(0.63)	(0.27)
	Book value	—	—	—	—	—	—	(4.44)	(3.70)	(2.19)	(2.38)
	Shares, m	—	—	—	—	—	—	8	7	8	10
Valuation, ×
Valuation, ×	P/E	—	—	—	—	—	—	20.57	20.57	15.85	0.00
	P/S	—	—	—	—	—	—	1.88	1.88	0.96	0.60
	P/B	—	—	—	—	—	—	0.00	0.00	0.00	0.00
	EV/Sales	—	—	—	—	—	—	2.69	2.69	1.50	1.33
	EV/FCF	—	—	—	—	—	—	53.35	53.35	(10.91)	(15.67)
Cash, $m
Cash, $m	Operating cash flow	—	—	—	—	—	—	(8)	0	(5)	(3)
	Capex	—	—	—	—	—	—	—	—	—	—
	Free cash flow	—	—	—	—	—	—	(8)	0	(5)	(3)
Balance, $m
Balance, $m	Working capital	—	—	—	—	—	—	(12)	(2)	(1)	2
	Total debt	—	—	—	—	—	—	22	26	20	25
	Net debt	—	—	—	—	—	—	19	25	19	22
	Shareholders’ equity	—	—	—	—	—	—	(34)	(27)	(17)	(23)
Returns, %
Returns, %	ROA	—	—	—	—	—	—	0.00	41.19	14.87	(93.11)
	ROIC	—	—	—	—	—	—	0.00	0.00	152.93	0.00
	ROE	—	—	—	—	—	—	0.00	(20.84)	(9.67)	62.08

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Mar 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
CAH Cardinal Health, Inc.	$58.8B	35.0×	23.3×	+5.84% (above 0%: growing)	+68.32% (above 0%: growing)	+10.87% (above 0%: growing)	4.02%	1.14%	Compare
HSIC Henry Schein, Inc.	$9.7B	25.0×	18.5×	+6.73% (above 0%: growing)	+16.90% (above 0%: growing)	+140.91% (above 0%: growing)	31.84%	4.95%	Compare
AHG Akso Health Group Sponsored ADR	$1.2B	— (loss-making)	— (loss-making)	+263.89% (above 0%: growing)	n/m	−12,975.04% (below 0%: shrinking)	0.00%	0.00%	Compare
FOCL FocalTherics	$154.8M	— (loss-making)	— (loss-making)	+38.85% (above 0%: growing)	n/m	+21.49% (above 0%: growing)	55.59%	(60.83%)	Compare
COSM Cosmos Health Inc.	$33.9M	— (loss-making)	25.1×	+28.76% (above 0%: growing)	n/m	+9.39% (above 0%: growing)	7.96%	(15.41%)	Compare
ACH Accendra Health, Inc.	$20.1M	— (loss-making)	— (loss-making)	−10.07% (below 0%: shrinking)	n/m	−1,624.82% (below 0%: shrinking)	42.95%	(5.73%)	Compare
HKPD Cellyan Biotechnology Co., Ltd	$17.1M	—	—	—	—	−90.45% (below 0%: shrinking)	—	—	Compare
YI 111, Inc. Sponsored ADR	$16.0M	— (loss-making)	— (loss-making)	−29.61% (below 0%: shrinking)	n/m	−185.70% (below 0%: shrinking)	5.33%	(0.85%)	Compare
SNYRQ Synergy CHC Corp.	$1.3M	— (loss-making)	1.6×	−32.77% (below 0%: shrinking)	n/m	−148.51% (below 0%: shrinking)	72.29%	(10.32%)
Median of peers	$94.3M	—	23.3×	+6.73%	—	−40.53%	7.96%	(0.85%)

All 11 Medical Distribution stocks →

Synergy CHC Corp. (SNYRQ) key facts

Concern: Synergy CHC Corp.’s revenue for fiscal 2025 (year ended December 2025) was $30.4 million, down 12.8% from fiscal 2024.
Synergy CHC Corp. (SNYRQ) is a Medical Distribution company in the Healthcare sector.
Return on equity was 62.1% and debt-to-equity -0.98.
Its Piotroski F-score is 2 out of 9 and its Altman Z-score is −7.00 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.